Short Interest in The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Grows By 216.2%

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the target of a significant increase in short interest in January. As of January 15th, there was short interest totalling 23,400 shares, an increase of 216.2% from the December 31st total of 7,400 shares. Based on an average trading volume of 28,300 shares, the days-to-cover ratio is currently 0.8 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Trading Up 1.4 %

NASDAQ:CGABL traded up $0.26 during trading hours on Thursday, reaching $18.96. The company had a trading volume of 19,651 shares, compared to its average volume of 25,050. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a 1-year low of $17.48 and a 1-year high of $20.85. The business’s 50 day moving average price is $18.55 and its 200-day moving average price is $19.15.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Saturday, February 15th. Stockholders of record on Saturday, February 1st will be given a $0.2891 dividend. The ex-dividend date of this dividend is Friday, January 31st. This is a boost from Carlyle Group Inc. 4.625% Subordinated Notes due 2061’s previous quarterly dividend of $0.29. This represents a $1.16 dividend on an annualized basis and a dividend yield of 6.10%.

About Carlyle Group Inc. 4.625% Subordinated Notes due 2061

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.